GlassScriptPhysician profile
Andrew A Konen
NPI 1467439166
$3,241.33
in general payments reported to CMS, 2019-2025
39 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $457 · 2021: $167 · 2022: $104 · 2023: $214 · 2024: $684 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $499.38 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Artisan |
| Abbvie INC. | $379.61 | 2021-2025 | |
| Nevro Corp. | $284.30 | 2019-2021 | |
| Abbott Laboratories | $228.04 | 2019-2025 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $220.25 | 2019-2025 | Xtampza |
| Allergan, INC. | $179.09 | 2019-2021 | |
| Pfizer INC. | $134.41 | 2019-2025 | |
| Spinal Simplicity, LLC | $113.60 | 2023-2025 | Ha Minuteman G3-R |
| Scilex Pharmaceuticals INC. | $94.00 | 2019-2021 | |
| Amgen INC. | $88.54 | 2019-2021 | |
| Assertio Therapeutics, INC. | $67.12 | 2019 | |
| Avanos Medical | $66.24 | 2021-2024 | On-Q* Pump and Accessories, Standard Rf Disposables |
| Novartis Pharmaceuticals Corporation | $66.08 | 2019-2020 | |
| Nalu Medical, INC. | $62.92 | 2021-2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $55.92 | 2024-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Konen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.